Evidence map›Paper›PMID 31162986›Full record

ArticleJournal of global oncology2019

Time Intervals From Onset of Clinical Manifestations to Treatment in Patients With Cancer at Hospital General San Felipe, Tegucigalpa, Honduras.

José A Sánchez, Mayra G Handal, Juan F Vílchez Rodriguez, Sinthia I Mejía, Annye P Pagoaga

Open access · goldAbstract read
In one paragraph

Article in Journal of global oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Healthcare stakeholders' perspectives on coordinating cancer diagnosis in Chile, Colombia, and Ecuador.Revista panamericana de salud publica = Pan American journal of public health · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

José A SánchezUniversidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Mayra G HandalUniversidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Juan F Vílchez RodriguezUniversidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Sinthia I MejíaUniversidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Annye P PagoagaUniversidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
National Autonomous University of Honduras · HN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn cancer, clinical staging is related to outcomes, and this is linked to the evolution of the disease over time. In Honduras, cancer mortality is high, and time intervals from onset of symptoms to treatment of cancer are not known. We conducted a cross-sectional study to determine these intervals. PATIENTS AND

methodsThis investigation was carried out from April 25 to August 30, 2018, and included 202 patients at the main cancer referral center in Honduras. For the purposes of the study, information was obtained from patients, their caregiver, medical records, or treatment cards. Patients older than age 18 years were included after informed consent was signed.

resultsThe mean time interval from onset of symptoms to cancer treatment was 232 days. Different intervals of time were identified, and the mean of these intervals was calculated in days as follows: 68 days from onset of symptoms to first medical evaluation; 146 days from first evaluation to oncologist consultation; 26 days from cancer specialist to the pathology report; and 86 days from the histopathologic diagnosis to the beginning of treatment. Once diagnosis was established, the average elapsed times to chemotherapy, radiotherapy, surgery, and chemoradiotherapy were 88, 102, 76, and 154 days, respectively (

conclusionThe mean time interval from symptom presentation to treatment in patients with cancer is more than 7 months. This could explain the advanced stages of disease seen at the time of treatment in Honduras, which decrease chance of cure and increase the mortality rate of cancer). Appropriate intervention to decrease these intervals must be taken to reduce mortality.

Indexed as

Time-to-TreatmentAdultAgedAged, 80 and overChemoradiotherapyCross-Sectional StudiesDrug TherapyFemaleHondurasHumansMaleMiddle AgedNeoplasmsNeoplasm StagingRadiotherapyRegistries

Identifiers

PMID31162986
PMCPMC6613713
OpenAlexW2949057792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.